...
首页> 外文期刊>Circulation. Cardiovascular imaging >Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy.
【24h】

Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy.

机译:肥厚型心肌病心肌隐窝的患病率和临床特征。

获取原文
获取原文并翻译 | 示例
           

摘要

In hypertrophic cardiomyopathy (HCM), cardiovascular MR can detect morphological abnormalities of the left ventricle (LV) not visualized with echocardiography. Although myocardial crypts (ie, narrow, blood-filled invaginations within the LV wall) have been recognized in HCM, all clinical implications of these structural abnormalities within the broad clinical HCM spectrum are not completely resolved. Therefore, we sought to characterize the prevalence and diagnostic significance of myocardial crypts in HCM patients.Cine and late gadolinium enhancement cardiovascular MR and 2-dimensional echocardiography were obtained in 292 consecutive patients with HCM including 31 genotype-positive/phenotype-negative family members without LV hypertrophy (28 ± 16 years; 51% male) and 261 patients with LV hypertrophy (46 ± 18 years; 60% male). Ninety-eight subjects without cardiovascular disease were controls. Myocardial crypts (1-6/patient) were identified only by cardiovascular MR in 19 of 31 genotype-positive/phenotype-negative patients (61%) compared with only 10 of 261 (4%) patients with HCM with LV hypertrophy (P<0.001) and were absent in control subjects. Twelve-lead electrocardiograms were normal in 10 (53%) of the genotype-positive/phenotype-negative patients with crypts. Crypts were confined to the basal LV, most commonly in the ventricular septum (n=21) or posterior LV free wall (n=4), and associated with normal LV contractility and absence of late gadolinium enhancement in all but one patient.LV myocardial crypts represent a distinctive morphological expression of HCM, occurring with different frequency in HCM patients with or without LV hypertrophy. Crypts are a novel cardiovascular MR imaging marker, which may identify individual HCM family members who should also be considered for diagnostic genetic testing. These data support an expanded role for cardiovascular MR in early evaluation of HCM families.
机译:在肥厚型心肌病(HCM)中,心血管MR可以检测超声心动图未显示的左心室(LV)形态异常。尽管在HCM中已经认识到了心肌隐窝(即,LV壁内狭窄,充满血液的内陷),但在广泛的HCM临床范围内,这些结构异常的所有临床意义尚未得到完全解决。因此,我们试图表征HCM患者心肌隐窝的患病率和诊断意义。连续292例HCM患者(包括31个基因型阳性/表型阴性家庭成员,没有合并肝癌和晚期g增强心血管MR和二维超声心动图)左室肥大(28±16岁;男性51%)和261例左室肥大(46±18岁; 60%男性)。无心血管疾病的98名受试者为对照。 31例基因型阳性/表型阴性患者中只有19例(61%)通过心血管MR识别出了心肌隐窝(261%),而LV肥厚的HCM 261例患者中只有10例(4%)(P < 0.001),并且在对照组中不存在。在有隐窝的基因型阳性/表型阴性患者中,有10例(53%)的十二导联心电图正常。隐窝仅限于基底LV,最常见于室间隔(n = 21)或左LV后壁(n = 4),并且除一名患者外,其余所有患者均具有正常的LV收缩力和缺乏absence增强。隐窝代表HCM的独特形态学表达,在有或无LV肥大的HCM患者中以不同的频率发生。隐窝是一种新颖的心血管MR成像标记,可识别单个HCM家庭成员,这些成员也应考虑用于诊断性基因检测。这些数据支持了心血管MR在HCM家庭早期评估中的扩展作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号